droxidopa has been researched along with Hemiplegia, Crossed in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kikuchi, K; Nishino, K; Ohyu, H | 1 |
1 other study(ies) available for droxidopa and Hemiplegia, Crossed
Article | Year |
---|---|
Increasing CNS norepinephrine levels by the precursor L-DOPS facilitates beam-walking recovery after sensorimotor cortex ablation in rats.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Brain Injury, Chronic; Cerebellum; Cerebral Cortex; Dominance, Cerebral; Droxidopa; Enzyme Inhibitors; Hemiplegia; Hippocampus; Male; Motor Cortex; Norepinephrine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Somatosensory Cortex | 2000 |